U.S. Water Utilities Stock News

NYSE:ICE
NYSE:ICECapital Markets

How Investors May Respond To Intercontinental Exchange (ICE) Earnings, Capital Returns And U.S. Treasury Clearing Expansion

In early February 2026, Intercontinental Exchange, Inc. reported past fourth-quarter and full-year 2025 results showing higher sales, revenue and earnings, while also raising its quarterly dividend to US$0.52 per share, authorizing up to US$3.00 billion in new share repurchases, and launching new products including FTSE South Korea RIC Capped Index Futures and Reddit Signals and Sentiment. ICE also secured past SEC approval to expand ICE Clear Credit into U.S. Treasury clearing, offering an...
NasdaqCM:NEGG
NasdaqCM:NEGGSpecialty Retail

Is Newegg Commerce (NEGG) Pricing Make Sense After Its Strong Recent Share Price Surge

If you are wondering whether Newegg Commerce's share price still reflects its fundamentals or if the market has run ahead of itself, you are in the right place. The stock closed at US$56.38, with returns of 13.5% over the past week, 13.9% over the past month, 7.8% year to date and a very large gain over the last year. Recent attention on Newegg Commerce has been driven by its positioning as an online tech focused retailer and ongoing interest in e commerce names. This can quickly change how...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk Lawsuit Tests Obesity Drug Patents And Valuation Upside

Novo Nordisk (NYSE:NVO) has filed a lawsuit against Hims & Hers, alleging patent infringement tied to compounded oral semaglutide products. The case centers on unapproved compounded versions of Novo Nordisk's obesity treatments as telehealth providers explore lower cost offerings. The company is also increasing advertising for Wegovy and Ozempic while competition in obesity care intensifies, including from Eli Lilly's Zepbound. Novo Nordisk, trading at $49.37, sits at the center of the...
NYSE:GLW
NYSE:GLWElectronic

Why Corning (GLW) Is Up 19.1% After Meta’s US$6 Billion AI Fiber Deal And Earnings Beat

Corning reported its fourth-quarter and full-year 2025 results, with sales rising to US$4,215 million and US$15.63 billion respectively, and net income increasing to US$540 million for the quarter and US$1.60 billion for the year. In a separate announcement, Meta Platforms disclosed a multiyear, up to US$6 billion agreement for Corning to supply advanced optical solutions and expand manufacturing capacity in North Carolina to support AI-focused data centers. Against this backdrop, we’ll...
NYSE:PAY
NYSE:PAYDiversified Financial

Is Paymentus (PAY) Turning Rapid Revenue And EPS Gains Into Lasting Competitive Strength?

Over the past two years, Paymentus Holdings has grown its cloud-based billing and payments platform for utilities, municipalities, and service providers, increasing market share as revenue expanded at 39% annually. An interesting aspect of this performance is that earnings per share rose even faster than sales, with very large incremental profitability gains across new business. We’ll now examine how this combination of strong revenue expansion and faster-growing earnings shapes Paymentus...
NasdaqGM:AIOT
NasdaqGM:AIOTElectronic

PowerFleet (AIOT) Q3 Loss Per Share Narrows Challenging Turnaround Narratives

PowerFleet (AIOT) has just posted its latest numbers, with Q2 2026 revenue at US$111.7 million and a basic EPS loss of US$0.03, setting the stage for how you read the new Q3 2026 update. Over recent periods the company has seen revenue move from US$75.4 million and an EPS loss of US$0.21 in Q1 2025 to US$106.4 million with an EPS loss of US$0.11 in Q3 2025, then to US$103.6 million and an EPS loss of US$0.09 in Q4 2025, and US$104.1 million with an EPS loss of US$0.08 in Q1 2026. With the...
NasdaqGM:MAZE
NasdaqGM:MAZEPharmaceuticals

Assessing Maze Therapeutics (MAZE) Valuation After Strong Recent Share Price Momentum

Why Maze Therapeutics (MAZE) Is On Investors’ Radar Maze Therapeutics (MAZE) has drawn fresh attention after recent trading, with the stock closing at $47.71 and showing strong trailing returns over the past year. This performance has prompted investors to reassess its clinical stage profile. See our latest analysis for Maze Therapeutics. The recent 5.95% 1 day share price return, on top of a 47.89% 90 day share price return and a very large 1 year total shareholder return of about 7x,...
NasdaqGS:MPAA
NasdaqGS:MPAAAuto Components

Motorcar Parts Of America (MPAA) Returns To Profitability Over Last Year Tests High 86x P/E Narrative

Motorcar Parts of America (MPAA) has put out its latest quarterly scorecard, with Q2 2026 revenue at US$221.47 million and basic EPS of a US$0.11 loss, alongside trailing twelve month revenue of US$789.12 million and basic EPS of US$0.13. Over the past few reported periods, the company has seen revenue move from US$169.89 million in Q1 2025 to US$208.19 million in Q2 2025, US$186.18 million in Q3 2025, US$193.11 million in Q4 2025, US$188.36 million in Q1 2026, and US$221.47 million in Q2...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian Deepens AI Push As New Products And Share Issuance Plans Emerge

Atlassian (NasdaqGS:TEAM) is expanding its artificial intelligence efforts with new AI driven products such as Rovo. The company is committing additional research and development resources to AI related projects. Management is describing AI as a transformative development for Atlassian's long term direction. A newly filed multibillion dollar shelf registration for Class A shares points to possible future capital raising or stock based compensation activity. For you as an investor, this...
NYSE:VG
NYSE:VGOil and Gas

Assessing Venture Global (VG) Valuation After Recent Share Price Rebound And 17.1% Undervaluation Estimate

Venture Global overview after recent price moves Venture Global (VG) has drawn attention after a recent share price move, with the stock closing at US$10.17 and showing mixed return patterns across the past week, month and past 3 months. See our latest analysis for Venture Global. Recent moves sit on top of a much bumpier year, with a year to date share price return of 44.46% and a 1 year total shareholder return decline of 40.50%, suggesting recent momentum has not yet fully repaired earlier...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock Weighs Crypto ETF Flows And Retirement Rethink For Investors

BlackRock's Bitcoin ETF, iShares Bitcoin Trust (IBIT), recently saw record trading volumes alongside major outflows tied to institutional activity and derivatives volatility. The firm is also pursuing mergers among several closed end funds as part of a broader set of shareholder value initiatives. In his latest annual letter, CEO Larry Fink called for a fundamental rethink of the retirement age in America, putting BlackRock at the center of a high profile policy debate. For investors...
NYSE:ANET
NYSE:ANETCommunications

Arista’s AI Data Center Rise Confronts Valuation And Concentration Risks

Arista Networks (NYSE:ANET) is expanding its role as a key supplier of ultra fast Ethernet platforms for hyperscale AI data centers. The company is closely tied to cloud giants' AI infrastructure buildouts, supplying networking gear that supports large scale AI workloads. Management faces pressure on margins and customer concentration risks as a small group of major clients accounts for a large share of business. Arista Networks, which focuses on high performance networking solutions for...
NYSE:HXL
NYSE:HXLAerospace & Defense

Assessing Hexcel (HXL) Valuation After Strong Recent Share Price Momentum

Hexcel’s recent performance and what it could mean for investors Hexcel (HXL) has attracted fresh attention after a strong past 3 months, with the stock showing a 25.03% total return and a 32.49% total return over the past year. See our latest analysis for Hexcel. At a share price of $86.06, Hexcel’s recent 7 day and 90 day share price returns of 5.48% and 25.03% sit alongside a 32.49% 1 year total shareholder return. This suggests momentum has been building rather than fading. If Hexcel’s...
NYSE:DUK
NYSE:DUKElectric Utilities

Assessing Duke Energy (DUK) Valuation After Recent Mixed Performance And Conflicting Fair Value Signals

What recent performance is signaling for Duke Energy (DUK) Duke Energy (DUK) has quietly outperformed over the past month, with a 4.2% return, while its past 3 months show a 1.6% decline, offering a mixed but interesting setup for income focused investors. See our latest analysis for Duke Energy. At a share price of $121.72, Duke Energy’s recent 7 day and 30 day share price returns of 1.9% and 4.2% sit alongside a 1 year total shareholder return of 9.1% and a 5 year total shareholder return...
NYSE:LUV
NYSE:LUVAirlines

Is Southwest (LUV) Using Dividends and Capacity Growth to Quietly Redefine Its Turnaround Story?

Southwest Airlines Co. recently reported past 2025 results showing slightly higher revenue of US$28,063 million but lower net income of US$441 million, alongside updated 2026 capacity and revenue guidance and a declared quarterly dividend of US$0.18 per share payable on April 2, 2026. The combination of modest earnings, softer load factors, capacity growth plans and continued capital returns offers a nuanced picture of Southwest’s ongoing turnaround efforts. Next, we’ll examine how...
NYSE:IQV
NYSE:IQVLife Sciences

Does IQVIA (IQV) Data Push and Buybacks Reveal a New Phase in Its Strategy?

IQVIA Holdings reported fourth-quarter 2025 sales of US$4,364 million and full-year sales of US$16,310 million, alongside issuing 2026 revenue guidance of US$17,150 million to US$17,350 million that factors in acquisition and foreign-exchange benefits. Recent moves, including a long-term Data-as-a-Service collaboration with Boehringer Ingelheim and ongoing share repurchases under a multi-year program, underline IQVIA’s push to deepen its role in data-driven healthcare decision-making. We’ll...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Is Down 8.7% After Il Makiage Slowdown Jitters And MethodIQ Spend Concerns

In its Q4 2025 investor letter, Baron Small Cap Fund cited Oddity Tech as a leading detractor, pointing to investor concerns about potential category weakness and signs of a slowdown at flagship brand Il Makiage based on industry commentary and credit card data. At the same time, Oddity Tech’s upcoming launch of its third platform, MethodIQ, introduces meaningful upfront marketing costs and added uncertainty to its financial profile. We’ll now examine how concerns about Il Makiage’s...
NYSE:VZ
NYSE:VZTelecom

Verizon Pricing Reset And Leadership Shift Put Valuation Gap In Focus

Verizon Communications (NYSE:VZ) has a new CEO, Dan Schulman, who is signaling a move away from frequent price hikes toward value-based pricing. Schulman is pairing this pricing reset with a stronger focus on customer experience for Verizon’s Consumer Group. The company is making major leadership changes within the Consumer Group as part of this broader shift. For you as an investor, this update touches the core of Verizon’s business: wireless and broadband services for millions of consumer...
NYSE:APH
NYSE:APHElectronic

Does Strong 2025 Results And Capital Returns Shift The Bull Case For Amphenol (APH)?

Amphenol Corporation recently reported strong 2025 results, including US$23.09 billion in sales and US$4.27 billion in net income, introduced first‑quarter 2026 sales guidance of US$6.90 billion to US$7.00 billion, declared a US$0.25 per‑share dividend for April 2026, and outlined leadership changes as longtime Chairman Martin H. Loeffler plans to retire. Taken together with ongoing share repurchases and the CEO’s planned transition to Chairman, these moves highlight Amphenol’s focus on...
NYSE:EQT
NYSE:EQTOil and Gas

EQT Dividend Declaration Highlights Cash Returns And Long Term Shareholder Story

EQT Corporation's Board of Directors has declared a quarterly cash dividend. The dividend decision reflects the company's ongoing commitment to returning cash to shareholders. The announcement arrives as EQT (NYSE:EQT) trades around $56.13 per share. EQT, trading at about $56.13, has attracted attention with multi year returns that are very large, including a 90.5% return over 3 years and a 238.3% return over 5 years. In the shorter term, the stock shows a 9.9% return over the past 30 days...
NYSE:GATX
NYSE:GATXTrade Distributors

Assessing GATX (GATX) Valuation As Recent Momentum Meets Conflicting Fair Value Signals

GATX stock in focus GATX (GATX) is drawing investor attention after recent share price moves, with the stock last closing at $189.13. That price sits alongside solid trailing returns and fresh fundamental data now available. See our latest analysis for GATX. Recent momentum has been firm, with a 7.5% 1 month share price return and a 21.3% 3 month share price return, contributing to a 3 year total shareholder return of 78.3%. This suggests strengthening sentiment rather than fading...
NYSE:BG
NYSE:BGFood

Assessing Bunge Global (BG) Valuation After Earnings Lift Sales But Pressure Profitability

Why Bunge Global (BG) Is Back in Focus After Its Latest Earnings Bunge Global (BG) is back on investors’ radar after its latest earnings, reporting fourth quarter sales of US$23,762 million and net income of US$95 million, compared with US$602 million a year earlier. See our latest analysis for Bunge Global. The latest earnings release appears to have reset expectations, yet the share price has still built momentum, with a 30 day share price return of 18.66% and a 1 year total shareholder...
NYSE:DGX
NYSE:DGXHealthcare

Assessing Quest Diagnostics (DGX) Valuation After Launch Of New Myeloma MRD Blood Test

Quest Diagnostics (DGX) just launched Quest Flow Cytometry MRD for Myeloma, a blood based test that measures residual disease in multiple myeloma and offers sensitivity comparable to next generation sequencing at a lower cost. See our latest analysis for Quest Diagnostics. Quest Diagnostics’ launch of the new myeloma MRD test comes as momentum has been gradually building, with the share price at US$191.25 and a 30 day share price return of 9.64%, while the 1 year total shareholder return...
NYSE:CLX
NYSE:CLXHousehold Products

Assessing Clorox (CLX) Valuation As Shares Show Fresh Short Term Momentum

Why Clorox (CLX) is back on many investors’ radar Clorox (CLX) has caught fresh attention after recent trading, with the stock now around $119.59 and showing positive returns over the past month and past 3 months. See our latest analysis for Clorox. Recent trading has added to that momentum, with a 30 day share price return of 12.62% and a 90 day share price return of 13.86%, even though the 1 year total shareholder return is still a 15.39% decline. This mix of shorter term strength and...